Dietary Treatment for Chronic Urticaria
NCT02047136 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2018-08-02
Summary
Histamine is a biologically active component that can be found in many foods and beverages. Intake of excessive histamine from foods or beverages, can trigger symptoms including urticaria. A low histamine diet has been recommended as one of the possible treatments for patients with chronic urticaria. There are very few studies to confirm the effectiveness of such diets and, to the investigators' knowledge, none from Asia where high histamine containing meals are often eaten (personal observations). The objective of the present study is to investigate the therapeutic effect of low histamine diet in relieving symptoms in patients with chronic urticaria with or without angioedema, and / or pruritus (U/A/P). The investigators hypothesize that following a low histamine diet for 4 weeks, the symptoms of patients with chronic U/A/P should improve.
Conditions
- Diet Modification
- Chronic Urticaria
Interventions
- OTHER
-
Treatment group (on low histamine diet)
78 subjects who come to Allergy Centre for treatment of idiopathic urticaria, with or without angioedema and pruritus (U/A/P), will be randomized into two parallel groups; treatment group (TG) will be asked to follow a histamine-restricted diet for 4 weeks and the control group (CG) will be asked to follow a well-balanced diet instructed by a dietitian for 4 weeks. A well-balanced diet for the CG subject is tailor-made by the dietitian according to subject's usual intake to ensure that the subject's energy requirement is met and all food groups are consumed.
- OTHER
-
Well-balanced diet
Diet tailor-made by the dietitian according to subject's usual intake to ensure that the subject's energy requirement is met and all food groups are consumed.
Sponsors & Collaborators
-
Hong Kong Sanatorium & Hospital
lead INDUSTRY
Principal Investigators
-
Wai Yan Vivian Lau, Master · Hong Kong Sanatorium & Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2017-12-31
- Completion
- 2018-07-31
Countries
- China
Study Locations
More Related Trials
-
The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis
NCT04976023 ·Status: COMPLETED ·Phase: PHASE2
-
Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses
NCT01250652 ·Status: COMPLETED ·Phase: PHASE4
-
Chronic Urticaria - Long Term Assessment of Effects of Rupatadine
NCT02358265 ·Status: TERMINATED ·Phase: PHASE3
-
The Diagnosis of Oral Allergy Syndrome Through the Use of a Structured Questionnaire
NCT00854958 ·Status: COMPLETED
-
Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency
NCT02565680 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis
NCT02027194 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers
NCT01068223 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
NCT00453583 ·Status: COMPLETED
-
Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
NCT02000648 ·Status: COMPLETED
-
Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)
NCT06608017 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use
NCT03883386 ·Status: TERMINATED ·Phase: PHASE2
-
Over-the-Counter Antihistamines & Heat Stress
NCT06217367 ·Status: RECRUITING ·Phase: PHASE4
-
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
NCT06819774 ·Status: RECRUITING ·Phase: PHASE3
-
Quality of Life in Patients With Chronic Urticaria
NCT03163875 ·Status: UNKNOWN
-
Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria
NCT06077773 ·Status: TERMINATED ·Phase: PHASE2
-
Herbal Treatment for Perennial Allergic Rhinitis
NCT00456755 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Perennial Allergic Rhinitis
NCT04234451 ·Status: UNKNOWN ·Phase: NA
-
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism
NCT01008592 ·Status: TERMINATED
-
Tranexamic Acid and Spontaneous Chronic Urticaria
NCT03789422 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Effects and Mechanisms of Yeast Postbiotics on Persistent Allergic Rhinitis Symptoms
NCT07079748 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis
NCT04815668 ·Status: RECRUITING ·Phase: NA
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)
NCT00751166 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
NCT06072157 ·Status: COMPLETED ·Phase: PHASE1